Cetera Investment Advisers Trims Stock Position in Edap Tms S.A. (NASDAQ:EDAP)

Cetera Investment Advisers lowered its stake in shares of Edap Tms S.A. (NASDAQ:EDAP) by 27.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 56,000 shares of the medical equipment provider’s stock after selling 20,944 shares during the period. Cetera Investment Advisers’ holdings in Edap Tms were worth $124,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Illumine Investment Management LLC purchased a new position in shares of Edap Tms during the 4th quarter valued at about $50,000. Jane Street Group LLC grew its position in shares of Edap Tms by 174.7% during the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after acquiring an additional 73,361 shares during the period. BNP Paribas Financial Markets grew its position in shares of Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 25,650 shares during the period. Schonfeld Strategic Advisors LLC grew its position in shares of Edap Tms by 48.5% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after acquiring an additional 52,500 shares during the period. Finally, Rock Springs Capital Management LP grew its position in shares of Edap Tms by 1.5% during the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock valued at $3,518,000 after acquiring an additional 23,800 shares during the period. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Price Performance

NASDAQ:EDAP opened at $1.81 on Tuesday. Edap Tms S.A. has a 12 month low of $1.26 and a 12 month high of $5.94. The stock has a 50 day moving average of $1.82 and a two-hundred day moving average of $2.17. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The firm has a market cap of $67.77 million, a P/E ratio of -2.79 and a beta of 0.13.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings data on Thursday, May 15th. The medical equipment provider reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.04). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The firm had revenue of $16.37 million for the quarter, compared to analysts’ expectations of $16.56 million. On average, analysts expect that Edap Tms S.A. will post -0.6 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Piper Sandler cut Edap Tms from an “overweight” rating to a “neutral” rating in a research report on Thursday, May 15th. HC Wainwright restated a “buy” rating and set a $19.00 target price on shares of Edap Tms in a research report on Friday, March 28th. Jefferies Financial Group restated a “hold” rating and set a $2.00 target price (down from $8.00) on shares of Edap Tms in a research report on Friday, April 4th. Finally, Wall Street Zen assumed coverage on Edap Tms in a research report on Thursday, May 15th. They set a “hold” rating on the stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.